Cargando…

The pathophysiology of Wilson’s disease visualized: A human (64)Cu PET study

BACKGROUND AND AIMS: Wilson’s disease (WD) is a genetic disease with systemic accumulation of copper that leads to symptoms from the liver and brain. However, the underlying defects in copper transport kinetics are only partly understood. We sought to quantify hepatic copper turnover in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandahl, Thomas Damgaard, Gormsen, Lars C., Kjærgaard, Kristoffer, Vendelbo, Mikkel Holm, Munk, Ditte Emilie, Munk, Ole Lajord, Bender, Dirk, Keiding, Susanne, Vase, Karina H., Frisch, Kim, Vilstrup, Hendrik, Ott, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305563/ https://www.ncbi.nlm.nih.gov/pubmed/34773664 http://dx.doi.org/10.1002/hep.32238

Ejemplares similares

Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [(64)Cu]copper PET/CT
por: Kjærgaard, Kristoffer, et al.
Publicado: (2020)

Distribution of non-ceruloplasmin-bound copper after i.v. (64)Cu injection studied with PET/CT in patients with Wilson disease
por: Munk, Ditte Emilie, et al.
Publicado: (2023)

Case report: Huppke–Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years
por: Kirk, Frederik Teicher, et al.
Publicado: (2022)

Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
por: Munk, Ditte Emilie, et al.
Publicado: (2022)

Human (13)N-ammonia PET studies: the importance of measuring (13)N-ammonia metabolites in blood
por: Keiding, Susanne, et al.
Publicado: (2010)

Hepatic bile acid transport increases in the postprandial state: A functional (11)C-CSar PET/CT study in healthy humans
por: Ørntoft, Nikolaj W., et al.
Publicado: (2021)

Clinical feasibility and impact of data-driven respiratory motion compensation studied in 200 whole-body (18)F-FDG PET/CT scans
por: Dias, André H., et al.
Publicado: (2022)

Tracer input for kinetic modelling of liver physiology determined without sampling portal venous blood in pigs
por: Winterdahl, Michael, et al.
Publicado: (2010)

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
por: Björklund, Jessica, et al.
Publicado: (2018)

Metabolic liver function measured in vivo by dynamic (18)F-FDGal PET/CT without arterial blood sampling
por: Horsager, Jacob, et al.
Publicado: (2015)

Edging closer to successful gene therapy for Wilson disease
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2022)

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease
por: Glavind, Emilie, et al.
Publicado: (2020)

Monitoring variables affecting positron emission tomography measurements of cerebral blood flow in anaesthetized pigs
por: Alstrup, Aage Kristian Olsen, et al.
Publicado: (2018)

Designing Clinical Trials in Wilson’s Disease
por: Ott, Peter, et al.
Publicado: (2021)

Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-(11)C]β-hydroxybutyrate ([(11)C]OHB) PET in healthy humans
por: Luong, Thien Vinh, et al.
Publicado: (2023)

Normal values for (18)F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients
por: Dias, André H., et al.
Publicado: (2022)

Renal PET-imaging with (11)C-metformin in a transgenic mouse model for chronic kidney disease
por: Pedersen, Lea, et al.
Publicado: (2016)

Magnetic resonance imaging and computed tomography as tools for the investigation of sperm whale (Physeter macrocephalus) teeth and eye
por: Alstrup, Aage Kristian Olsen, et al.
Publicado: (2017)

In vivo vesicular acetylcholine transporter density in human peripheral organs: an [(18)F]FEOBV PET/CT study
por: Horsager, Jacob, et al.
Publicado: (2022)

Wilson Disease: Update on Pathophysiology and Treatment
por: Dev, Som, et al.
Publicado: (2022)

Multiparametric dynamic whole-body PSMA PET/CT using [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007
por: Dias, André H., et al.
Publicado: (2023)

Meson spectroscopy and decay constants with Wilson fermions at $\beta$ = 6.4
por: Abada, A, et al.
Publicado: (1991)

Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value
por: Pedersen, Mette Abildgaard, et al.
Publicado: (2023)

Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
por: Munk, Kim, et al.
Publicado: (2015)

Metabolic liver function in humans measured by 2-(18)F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential
por: Bak-Fredslund, Kirstine P., et al.
Publicado: (2017)

Clinical validation of a population-based input function for 20-min dynamic whole-body (18)F-FDG multiparametric PET imaging
por: Dias, André H., et al.
Publicado: (2022)

Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives
por: Kjærgaard, Kristoffer, et al.
Publicado: (2021)

Extracardiac findings with increased perfusion during clinical O-15-H(2)O PET/CT myocardial perfusion imaging: A case series
por: Jochumsen, Mads Ryø, et al.
Publicado: (2023)

Heavy flavor meson decay constants with Wilson fermions at beta = 6.4
por: Abada, A, et al.
Publicado: (1992)

The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study
por: Jepsen, Peter, et al.
Publicado: (2009)

Therapeutic strategies in Wilson disease: pathophysiology and mode of action
por: Stremmel, Wolfgang, et al.
Publicado: (2021)

No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation
por: Støy, Sidsel, et al.
Publicado: (2021)

Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component
por: Ortiz, Juan Fernando, et al.
Publicado: (2020)

Single time point quantitation of cerebral glucose metabolism by FDG-PET without arterial sampling
por: Cumming, Paul, et al.
Publicado: (2023)

Correction: Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis
por: Støy, Sidsel, et al.
Publicado: (2018)

Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis
por: Støy, Sidsel, et al.
Publicado: (2018)

Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [(11)C]acetate in humans
por: Iversen, Peter, et al.
Publicado: (2014)

Reply to Letter to the Editor: Neurocognitive impairment in obesity and liver disease—An unsolved mystery
por: Wernberg, Charlotte Wilhelmina, et al.
Publicado: (2023)

Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course
por: Støy, Sidsel, et al.
Publicado: (2013)

Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression
por: Støy, Sidsel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9r4fhbqe3fnqu9lrrivqu6c4lo